Research Comparison
GHRP-6 vs Ipamorelin
A side-by-side research comparison of GHRP-6 and Ipamorelin drawn from Cedar Peptides' peptide database records.
GHRP-6
GHRP-6 (Growth Hormone Releasing Peptide-6) is a synthetic hexapeptide belonging to the growth hormone secretagogue (GHS) class. It stimulates endogenous growth hormone (GH) release via activation of the ghrelin receptor (GHS-R1a) in the hypothalamus and anterior pituitary. As one of the earliest developed GHRPs, GHRP-6 is well-characterised and widely used in research investigating GH pulsatility, appetite signalling, and metabolic regulation. It is known for its strong orexigenic (appetite-stimulating) effects in addition to GH release.
Ipamorelin
Ipamorelin is a selective growth hormone releasing peptide (GHRP) that stimulates endogenous growth hormone (GH) secretion via activation of ghrelin (GHS-R1a) receptors in the pituitary. It is characterized by a highly selective profile, producing GH release without significant stimulation of cortisol or prolactin. This selectivity distinguishes it from earlier GHRPs, making it a preferred compound in research focused on body composition, recovery, sleep, and anti-aging. Its ability to preserve physiological GH pulsatility while minimizing off-target endocrine effects has positioned it as a core peptide in GH optimization protocols.
Reading a comparison
A comparison places two records side by side; it does not merge them. Each description above is drawn from that compound's own record, and the two were not necessarily characterised by the same methods, at the same time, or to the same level of detail. Before comparing any attribute, it is worth establishing that both records describe the substance you think they describe — names are not identifiers, and two entries sharing a name can differ in salt form, stereochemistry or the convention used to state a mass. Where a figure carries no method beside it, the comparison is between two reported numbers rather than between two measurements.